Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00614315 · ClinicalTrials.gov registry record · NA

FLAIR™ Delivery System Study

A NA study, sponsored by C. R. Bard.

Completed
Registry status
NA
Development phase
30
Enrollment target

NCT00614315 is a NA study that has completed, run by C. R. Bard. The registered enrollment target is 30 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00614315, a NA study, has completed, sponsored by C. R. Bard.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

The objective of this clinical study is to evaluate the performance of the Optimized FLAIR™ Delivery System.

Interventions

  • DEVICE FLAIR™ Endovascular Stent Graft

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2007-12
Est. Completion 2008-02
Phase NA

Sponsor

C. R. Bard

75 total trials

What the Registry Record Tells You About NCT00614315

The ClinicalTrials.gov registry entry for NCT00614315 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is C. R. Bard, which has 75 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which FLAIR™ Endovascular Stent Graft is the first listed.

NCT00614315 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00614315 about?

NCT00614315 is a clinical study titled "FLAIR™ Delivery System Study". The objective of this clinical study is to evaluate the performance of the Optimized FLAIR™ Delivery System.

What is the current status of trial NCT00614315?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2007-12. Estimated completion is 2008-02.

What interventions are being tested in trial NCT00614315?

The interventions under investigation include: FLAIR™ Endovascular Stent Graft (DEVICE).

Who is sponsoring clinical trial NCT00614315?

This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.